Anika to Participate in the Sidoti Virtual Investor Conference

Rhea-AI Summary

Anika Therapeutics (NASDAQ: ANIK), a leader in osteoarthritis pain management and regenerative solutions, has announced its participation in the upcoming Sidoti Virtual Investor Conference. The company's management will deliver a virtual presentation followed by a Q&A session on Wednesday, May 21, 2025, at 1:00 PM ET. Investors can access the live webcast through Anika's Investor Relations website section at www.anika.com, where an archived version will also be available for later viewing.

News Market Reaction

+1.73%

1 alert

+1.73% News Effect

On the day this news was published, ANIK gained 1.73%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

BEDFORD, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that management will participate in the Sidoti Virtual Investor Conference on Wednesday, May 21, 2025. Anika will host a virtual presentation with Q&A starting at 1:00pm ET.

Webcast of the presentation and Q&A will be available in the Investor Relations section of Anika’s website, www.anika.com. An archive of the presentation will also be available on the website.

About Anika

Anika Therapeutics, Inc. (NASDAQ: ANIK), is the global leader in the design, development, manufacturing, and commercialization of hyaluronic acid (“HA”) innovations. In partnership with clinicians, our sole focus is dedicated to delivering and advancing osteoarthritis (“OA”) pain management and orthopedic regenerative solutions. At our core is a passion to deliver a differentiated portfolio that improves patient outcomes around the world. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.

ANIKA, ANIKA THERAPEUTICS and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.

For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com

FAQ

When is Anika Therapeutics (ANIK) presenting at the Sidoti Virtual Investor Conference?

Anika Therapeutics will present at the Sidoti Virtual Investor Conference on Wednesday, May 21, 2025, at 1:00 PM ET.

How can investors watch Anika's (ANIK) Sidoti conference presentation?

Investors can watch the presentation through the webcast available in the Investor Relations section of Anika's website at www.anika.com.

What is Anika Therapeutics' (ANIK) main business focus?

Anika Therapeutics is a global leader in osteoarthritis pain management and regenerative solutions, focusing on early intervention orthopedics.

Will there be a replay available of Anika's (ANIK) Sidoti conference presentation?

Yes, an archive of the presentation will be available on Anika's website at www.anika.com.